Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_assertion type Assertion NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_head.
- NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_assertion description "[These data implicate PTP-MEG2 as a mediator of blood glucose homeostasis through antagonism of insulin signaling, and suggest that modulation of PTP-MEG2 activity may be an effective strategy in the treatment of type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_provenance.
- NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_assertion evidence source_evidence_literature NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_provenance.
- NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_assertion SIO_000772 16679294 NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_provenance.
- NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_assertion wasDerivedFrom befree-20140225 NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_provenance.
- NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_assertion wasGeneratedBy ECO_0000203 NP891046.RA4aU0phT7lbVC2H6sHL8r81OXIrjdPaFK_EmjKUC7Rs4130_provenance.